Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.

Cancer Medicine
Anne Gulbech OrdingPeter Brønnum Nielsen

Abstract

Direct oral anticoagulants (DOACs) may increase the risk of gastrointestinal (GI) bleeding in patients with atrial fibrillation (AF) and GI cancer compared with vitamin K antagonists (VKA). We conducted a Danish nationwide cohort study comparing the bleeding risk associated with DOAC versus VKA in patients with AF and GI cancer. We calculated crude bleeding rates per 100 person-years (PYs) for GI and major bleeding. We then compared rates of bleeding at 1 year after initial oral anticoagulation filled prescription by treatment regimen using inverse probability of treatment weighting and Cox regression. The unweighted study population included 1476 AF patients with GI cancer (41.6% women, median age 78 years) initiating a DOAC and 652 initiating a VKA. One-year risk of GI bleeding was 5.0% in the DOAC group and 4.7% in the VKA group with a corresponding weighted hazard ratio (HR) of 0.95 (95% confidence interval [CI]: 0.63, 1.45). For patients with active cancer, weighted GI bleeding rates were slightly higher in both the VKA and DOAC group, and the weighted HR was 1.00 (95% CI: 0.53, 1.88). The HR was 1.12 (95% CI: 0.71, 1.76) for all bleedings. Hazard ratios for GI bleeding were 0.61 (95% CI: 0.25, 1.52) for patients with uppe...Continue Reading

References

Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Aug 4, 2011·Scandinavian Journal of Public Health·Marianne Lundkjær Gjerstorff
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Jan 19, 2012·International Journal of Epidemiology·Per Kragh AndersenHein Putter
Mar 20, 2013·Statistics in Medicine·Daniel F McCaffreyLane F Burgette
Nov 12, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·S Casey LaizureZhe-Yi Hu
Jun 27, 2014·European Journal of Epidemiology·Morten SchmidtHenrik Toft Sørensen
Nov 26, 2015·Clinical Epidemiology·Morten SchmidtHenrik Toft Sørensen
Oct 22, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kathryn F FlackJames Aisenberg
Aug 6, 2018·International Journal of Cardiology·Maria Cristina VedovatiCecilia Becattini
Sep 17, 2018·European Heart Journal. Quality of Care & Clinical Outcomes·Sean T ChenChiara Melloni
Oct 30, 2018·Journal of the American Heart Association·Christina L FanolaRobert P Giugliano
Mar 23, 2019·Journal of the American College of Cardiology·Ramya C MosarlaRobert P Giugliano
Apr 23, 2019·American Journal of Hematology·Dana E AngeliniAlok A Khorana
Mar 31, 2020·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN Caravaggio Investigators
Jul 28, 2020·Circulation Research·Jelena KornejRenate B Schnabel
Jan 26, 2021·European Heart Journal. Cardiovascular Pharmacotherapy·Danilo MenichelliDaniele Pastori

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.